Assessment of Surface Coverage of Two Types of Drug-eluting Stent in Diabetes Mellitus and Non-Diabetes Mellitus

Exclusion Criteria

• •1. ST-segment elevation myocardial infarction within 7 days prior to the index procedure.
• •2. Life expectancy \<12 months due to another medical condition.
• •3. Contraindication to antiplatelet therapy or a history of hypersensitivity to sirolimus and paclitaxel or structurally related compounds.
• •4. Creatinine level more than 2.0mg/dL or ESRD.
• •5. Severe hepatic dysfunction (more than 3 times normal reference values).
• •6. Planned surgery procedure≤12 months post-index procedure.
• •7. Known allergy to stainless steel.
• •8. Female of childbearing potential with a positive pregnancy test within 7 days before the index procedure, or lactating, or intends to become pregnant during the 12 months post index procedure.
• •9. Patient is not clinically appropriate for OCT evaluation in the opinion of investigator.
• •1. Study lesion is ostial in location (within 3.0 mm of vessel origin).
• •2. Study lesion involving arterial segments with highly tortuous anatomy.
• •3. Complex lesion morphologies (bifurcation needs two stents technique, left main lesion, chronic obstructive occlusion, severe thrombus, heavy calcification).